Nanograb
- Biotech or pharma, therapeutic R&D
We are a pre-clinical stage startup that leverages AI and molecular simulations to design combinations of binders against proteins for cell selective targeting. By applying our platform to LNPs, we increase gene delivery to the target cell type and decrease delivery to off targets.